Elsevier

Seminars in Hematology

Volume 37, Issue 4, October 2000, Pages 320-333
Seminars in Hematology

Fluorescence in situ hybridization: Uses and limitations

https://doi.org/10.1016/S0037-1963(00)90013-1Get rights and content

Abstract

The development of molecular hybridization techniques such as fluorescence in situ hybridization (FISH) has had a major Impact on efforts to detect and characterize the genetic changes that give rise to human tumors. With probes designed to identify specific chromosomes and chromosomal regions, FISH is used routinely by cytogenetics and pathology laboratories to identify recurring chromosomal abnormalities associated with hematologic malignant diseases. In many cases FISH analysis provides increased sensitivity, in that cytogenetic abnormalities have been found in samples that appeared to be normal by morphologic and conventional cytogenetic examination. The combination of cytogenetic, FISH, and molecular analyses provides a powerful approach for diagnosing and subclassifying malignant diseases into clinically and biologically relevant subgroups, in selecting appropriate therapy, and in monitoring the efficacy of therapeutic regimens.

References (59)

  • SM Escudier et al.

    Fluorescent in situ hybridization and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemia

    Blood

    (1993)
  • K Fischer et al.

    Design and validation of DNA probe sets for a comprehensive interphase cytogenetic analysis of acute myeloid leukemia

    Blood

    (1996)
  • R Fonseca et al.

    Cytogenetic abnormalities in multiple myeloma

    Hematol Oncol Clin North Am

    (1999)
  • JA Garcia-Marco et al.

    Interphase cytogenetics in chronic lymphocytic leukemia

    Cancer Genet Cytogenet

    (1997)
  • M Hallek et al.

    Multiple myeloma: Increasing evidence for a multistep transformation process

    Blood

    (1998)
  • WJ Hogan et al.

    Prognostic relevance of monosomy at the 13q14 locus detected by fluorescence in situ hybridization in B-cell chronic lymphocytic leukemia

    Cancer Genet Cytogenet

    (1999)
  • RB Jenkins et al.

    Interphase fluorescence in situ hybridization: A sensitive method for trisomy 8 detection in bone marrow specimens

    Blood

    (1992)
  • S Kalachikov et al.

    Cloning and gene mapping of the chromosome 13q14 region deleted in chronic lymphocytic leukemia

    Genomics

    (1997)
  • JE Landegent et al.

    2-Acetylaminofluorene-modified probes for the indirect hybridocytochemical detection of specific nucleic acid sequences

    Exp Cell Res

    (1984)
  • JY Li et al.

    Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization

    Am J Pathol

    (1999)
  • K Nishida et al.

    The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization

    Blood

    (1997)
  • JA Perez-Simon et al.

    Prognostic value of numerical chromosome aberrations in multiple myeloma: A FISH analysis of 15 different chromosomes

    Blood

    (1998)
  • SP Romana et al.

    High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia

    Blood

    (1995)
  • D Ronchetti et al.

    Molecular analysis of 11q13 breakpoints in multiple myeloma

    Blood

    (1999)
  • PB Sinclair et al.

    Improved sensitivity of BCR-ABL detection: A triple probe three-color fluorescence in situ hybridization system

    Blood

    (1997)
  • P Starostik et al.

    The prognostic significance of 13q14 deletions in chronic lymphocytic leukemia

    Leuk Res

    (1999)
  • G Tricot et al.

    Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities

    Blood

    (1995)
  • M Zandecki et al.

    Several subclones may be identified within plasma cells of patients with monoclonal gammopathy of undetermined significance, both at diagnosis and during the indolent course of the condition

    Blood

    (1997)
  • N Zojer et al.

    Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by fluorescence in situ hybridization

    Blood

    (2000)
  • Cited by (129)

    • Leukemias, Lymphomas, and Plasma Cell Disorders

      2022, Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics: Hematologic, Renal, and Immunologic Disorders
    View all citing articles on Scopus
    View full text